AM-2201
2.5 ★
2.5 ★
735 Ratings
5 ★
0
4 ★
168
3 ★
167
2 ★
175
1 ★
156
(735)
Highlights:
AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor.[1] It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.
€265.00 – €3,200.00
Select options
This product has multiple variants. The options may be chosen on the product page